NULISAseq CNS Disease Panel 120 Expanded with Blood-Based Brain-Derived pTau Assays
Alamar Biosciences has expanded its NULISAseq CNS Disease Panel 120 to include highly sensitive, blood-based assays.
Latest Articles
Editor's Top Picks
Measuring the Score: LDTs 1 – Science 0
The ruling overturning the FDA’s new regulations covering LDTs is good news. But the growing anti-science bias could impact healthcare more.
Diagnostic Innovations
Cell Analyzer Gets Global Launch
BD has launched the BD FACSDiscover A8 Cell Analyzer, integrating advanced spectral and real-time imaging technologies.
Equipment & Supply Spotlight
Thermo Scientific 1500 Series Class II, Type A2 Biological Safety Cabinet Introduced
Thermo Fisher has launched the 1500 Series Class II, Type A2 Biological Safety Cabinet, enhancing lab safety and operational efficiency.
News, Know-How & Standards
Disease Detection & Understanding
At-Home Self-Collection Device for Cervical Cancer Screening Gets FDA Approval
Teal Health has received FDA approval for the Teal Wand, a prescription-based self-collection device for cervical cancer screening.
